Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luís Puga has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real-world assessment of multipolar and point-by-point mapping for premature ventricular contraction ablation

    by Pedro A Sousa, Johanna Tonko, Dagmara Dilling-Boer, Sérgio Barra, Anna-Sophie Eberl, Borka Pezo, Nuno Cortez-Dias, Ziad Khoueiry, Paulo Medeiros, Moisés Rodríguez-Mañero, et al.

    Aims: We aimed to assess the acute and midterm efficacy of premature ventricular contraction (PVC) ablation guided by multielectrode and point-by-point (PbP) mapping. Methods and results: This is a retrospective, international multicentre study of consecutive patients referred for PVC ablation in 10 hospital centres from January 2017 to December 2021. Based on the mapping approach, two cohorts were identified: the ‘Multipolar group’, where a dedicated high-density mapping catheter was employed, and the ‘PbP group’, where mapping was performed with the ablation catheter. Procedural endpoints, safety, and acute (procedural) and midterm efficacies were assessed. Of the 698 patients included in this study, 592 received activation mapping [46% males, median age of 55 (41–65) years]—248 patients in the Multipolar group and 344 patients in the PbP group. A higher number of activation points [432 (217–843) vs. 95 (42–185), P < 0.001], reduced mapping time (40 ± 38 vs. 61 ± 50 min, P < 0.001), and shorter procedure time (124 ± 60 vs. 143 ± 63 min, P < 0.001) were reported in the Multipolar group. Both groups had high acute success rates (84.7% with Multipolar mapping vs. 81.3% with PbP mapping, P = 0.63), as well as midterm efficacy (83.4% vs. 77.4%, P = 0.08), with no significant differences in the risk of adverse events (6.0% vs. 3.5%, P = 0.24). However, for left-sided PVC ablation specifically, there was a higher midterm efficacy in the Multipolar group (80.7% vs. 69.5%, P = 0.04), with multipolar mapping being an independent predictor of success [adjusted OR = 2.231 (95% CI, 1.476–5.108), P = 0.02]. Conclusion: The acute and midterm efficacies of PVC ablation are high with both multipolar and PbP mapping, although the former allows for quicker procedures and may potentially improve the outcomes of left-sided PVC ablation.


  • Open Access

    Ostial vs. wide area circumferential ablation guided by the Ablation Index in paroxysmal atrial fibrillation

    by Pedro A Sousa, Sérgio Barra, Carolina Saleiro, Ziad Khoueiry, Luís Adão, João Primo, Philippe Lagrange, Ana Lebreiro, Paulo Fonseca, Mariana Pereira, et al.

    Pulmonary vein isolation (PVI) guided by the Ablation Index (AI) has shown high acute and mid-term efficacy in the treatment of paroxysmal atrial fibrillation (AF). Previous data before the AI-era had suggested that wide-area circumferential ablation (WACA) was preferable to ostial ablation. However, with the use of AI, we hypothesize that ostial circumferential ablation is non-inferior to WACA and can improve outcomes in paroxysmal AF. Prospective, multicentre, non-randomized, non-inferiority study of consecutive patients were referred for paroxysmal AF ablation from January 2020 to September 2021. All procedures were performed using the AI software, and patients were separated into two different groups: WACA vs. ostial circumferential ablation. Acute reconnection, procedural data, and 1-year arrhythmia recurrence were assessed. During the enrolment period, 162 patients (64% males, mean age of 60 ± 11 years) fulfilled the study inclusion criteria—81 patients [304 pulmonary vein (PV)] in the WACA group and 81 patients (301 PV) in the ostial group. Acute PV reconnection was identified in 7.9% [95% confidence interval (CI), 4.9–11.1%] of PVs in the WACA group compared with 3.3% (95% CI, 1.8–6.1%) of PVs in the ostial group [P < 0.001 for non-inferiority; adjusted odds ratio 0.51 (95% CI, 0.23–0.83), P = 0.05]. Patients in the WACA group had longer ablation (35 vs. 29 min, P = 0.001) and procedure (121 vs. 102 min, P < 0.001) times. No significant difference in arrhythmia recurrence was seen at 1-year of follow-up [11.1% in WACA vs. 9.9% in ostial, hazard ratio 1.13 (95% CI, 0.44–1.94), P = 0.80 for superiority]. In paroxysmal AF patients treated with tailored AI-guided PVI, ostial circumferential ablation is not inferior to WACA with regard to acute PV reconnection, while allowing quicker procedures with less ablation time. Distribution of acute pulmonary vein reconnection in both groups [wide-area circumferential ablation (WACA) vs. ostial] (central panel), with an illustration of the typical location for ablation lines in each corresponding group, in a posterior view (left panel). Ostial ablation was not inferior to WACA with regard to acute pulmonary vein reconnections (P < 0.001 for non-inferiority; P = 0.05 adjusted for superiority) and arrhythmia recurrence at 1-year of follow-up (P < 0.001 for non-inferiority; P = 0.80 for superiority), while requiring less ablation (P = 0.001) and allowing for quicker procedures (P < 0.001) (right panel).


  • Open Access

    Transcatheter Tricuspid Valve Replacement: Illustrative Case Reports and Review of State-of-Art

    by Manuel Barreiro-Pérez, Rocío González-Ferreiro, Berenice Caneiro-Queija, Marta Tavares-Silva, Luis Puga, Jose A Parada-Barcia, Alvaro Rodriguez-Perez, Jose A Baz-Alonso, Miguel A Pinon-Esteban, Rodrigo Estevez-Loureiro, et al.

    Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation. Surgery is the standard treatment for TR, although it is associated with high morbidity, mortality, and prolonged hospitalization, particularly in tricuspid reoperation after left-sided surgery. Thus, several innovative percutaneous transcatheter approaches for repair and replacement of the tricuspid valve have gathered significant momentum and have undergone extensive clinical development in recent years, with favorable clinical outcomes in terms of mortality and rehospitalization during the first year of follow-up. We present three clinical cases of transcatheter tricuspid valve replacement in an orthotopic position with two different innovative systems along with a review of the state-of-the-art of this emergent topic.


  • Cardiovalve Transfemoral Tricuspid Valve Replacement Assisted With CT–Fluoroscopy Fusion Imaging

    by Manuel Barreiro-Perez, Rodrigo Estevez-Loureiro, Jose Antonio Baz, Miguel A. Piñón, Francesco Maisano, Luis Puga, Berenice Caneiro-Queija, Andres Iñiguez-Romo


  • Assessment of the need of a waiting period after pulmonary vein isolation with the ablation index software

    by Pedro A. Sousa, Sérgio Barra, Luís Adão, João Primo, Ziad Khoueiry, Luís Puga, Ana Lebreiro, Paulo Fonseca, Philippe Lagrange, Lino Gonçalves, et al.

    Purpose: Since the widespread availability of contact‐force sensing catheters, the need for a waiting period after pulmonary vein isolation (PVI) has not been reassessed. We aim to evaluate whether a waiting period is still necessary after PVI guided by the ablation Index (AI).Methods: Prospective, multicenter, randomized study of consecutive patients referred for paroxysmal atrial fibrillation (AF) ablation from May 2019 to February 2020. Patients were randomized in a 1:1 ratio to PVI with versus without a waiting period of 20 min. Acute pulmonary vein (PV) reconnection after adenosine challenge was the primary endpoint. A per‐protocol analysis was designed to determine whether a strategy of dismissing the waiting period after PVI was noninferior to waiting for 20 min for identifying acute PV reconnection. PVI was guided by tailored AI values and an interlesion distance ≤6 mm.Results: During the enrollment period, 167 patients (56% males, mean age of 57 ± 14 years) fulfilled the study inclusion criteria – 84 patients (308 PV) in the waiting period group (Group A) and 83 patients (314 PV) in the group without a waiting period (Group B). Acute PV reconnection was identified in 3.8% (95% confidence interval [CI], 1.7%–5.9%) of PVs in the study group B compared to 2.9% (95% CI, 1.0%–4.8%) of PVs in the Group A (p = .002 for non‐inferiority). At 1‐year follow‐up, there was no significant difference in arrhythmia recurrence between groups (9.5% in Group A vs. 9.6% in Group B, hazard ratio: 1.03 [95% CI, 0.39–2.73], p = .98).Conclusion: In paroxysmal AF patients submitted to ablation, a tailored PVI guided by the AI rendered a 20‐min waiting period unnecessary.


  • Open Access

    Two years after pulmonary vein isolation guided by ablation index—a multicenter study

    by Pedro A. Sousa, Luís Puga, Luís Adão, João Primo, Ziad Khoueiry, Ana Lebreiro, Paulo Fonseca, Philippe Lagrange, Luís Elvas, Lino Gonçalves

    Background: The use of the Ablation Index (AI) software for paroxysmal atrial fibrillation (AF) has been associated with higher acute effectiveness and higher 1-year arrhythmia freedom. There is, however, a lack of data concerning longer follow-up. We aim to evaluate the 2-year outcomes after a standardized AI-guided pulmonary vein isolation (PVI). Methods: Prospective, multicenter study of consecutive patients referred for paroxysmal AF ablation from January 2018 to July 2019. PVI was guided by a tailored AI value (>= 500 for anterior segment, >= 450 for the roof segments and inferior segments, and 400 for the posterior wall) and an ILD <= 6 mm. The primary endpoints were acute and long-term effectiveness. Results: The study included 218 (842 PV) patients (61% males, median age of 60 [IQR 49-68] years) with paroxysmal AF. First-pass isolation was obtained in 93% of the patients, with an acute reconnection occurring in 10.6% of the patients (3.2% of the PV) following adenosine trial. After a median follow-up of 26 (IQR 20-30) months, freedom from any documented atrial arrhythmia was 83.4%, off-AAD. The rate of adverse events was 1.4%. Although procedural parameters differ across centers (p < 0.001), the acute (p = 0.56) and long-term effectiveness (p = 0.83) were consistent between centers. Conclusions: Patients with paroxysmal AF submitted to an AI-guided PVI workflow presented high arrhythmia freedom at 2-years of follow-up.


  • Open Access

    Imaging in Transcatheter Mitral Valve Replacement: State-of-Art Review

    by Manuel Barreiro-Perez, Berenice Caneiro-Queija, Luis Puga, Rocío Gonzalez-Ferreiro, Robert Alarcon, Jose Antonio Parada, Andrés Iñiguez-Romo, Rodrigo Estevez-Loureiro

    Mitral regurgitation is the second-most frequent valvular heart disease in Europe and it is associated with high morbidity and mortality. Recognition of MR should encourage the assessment of its etiology, severity, and mechanism in order to determine the best therapeutic approach. Mitral valve surgery constitutes the first-line therapy; however, transcatheter procedures have emerged as an alternative option to treat inoperable and high-risk surgical patients. In patients with suitable anatomy, the transcatheter edge-to-edge mitral leaflet repair is the most frequently applied procedure. In non-reparable patients, transcatheter mitral valve replacement (TMVR) has appeared as a promising intervention. Thus, currently TMVR represents a new treatment option for inoperable or high-risk patients with degenerated or failed bioprosthetic valves (valve-in-valve); failed repairs, (valve-in-ring); inoperable or high-risk patients with native mitral valve anatomy, or those with severe annular calcifications, or valve-in-mitral annular calcification. The patient selection requires multimodality imaging pre-procedural planning to select the best approach and device, study the anatomical landing zone and assess the risk of left ventricular outflow tract obstruction. In the present review, we aimed to highlight the main considerations for TMVR planning from an imaging perspective; before, during, and after TMVR.


  • Simultaneous transcatheter pulmonary and tricuspid valve-in-ring implantation

    by Diogo Faim, Patrícia V. Silva, José L. Zunzunegui, Luís Puga, Andreia Francisco, Dina Rodrigues, António Pires

    We report on a 50-year-old female patient, with several severe comorbidities and high-surgical risk, in whom we successfully performed a simultaneous transcatheter pulmonary and tricuspid valve-in-ring implantation to treat both bioprosthetic pulmonary valve dysfunction and native torrential tricuspid valve regurgitation, the latter previously managed with a Carpentier annuloplasty ring.

  • Cardiovascular Risk Assessment after COVID-19 Infection before Resuming Sports Activities - Practical Flowchart and Meta-Analysis

    by Luís Puga, Paulo Dinis, Rogério Teixeira, Joana Maria Ribeiro, Hélder Dores, Lino Gonçalves

    Background: The risk of sports-related sudden cardiac arrest after COVID-19 infection can be a serious problem. There is an urgent need for evidence-based criteria to ensure patient safety before resuming exercise. Objective: To estimate the pooled prevalence of acute myocardial injury caused by COVID-19 and to provide an easy-to-use cardiovascular risk assessment toolkit prior to resuming sports activities after COVID-19 infection. Methods: We searched the Medline and Cochrane databases for articles on the prevalence of acute myocardial injury associated [...] Abstract Background: The risk of sports-related sudden cardiac arrest after COVID-19 infection can be a serious problem. There is an urgent need for evidence-based criteria to ensure patient safety before resuming exercise. Objective: To estimate the pooled prevalence of acute myocardial injury caused by COVID-19 and to provide an easy-to-use cardiovascular risk assessment toolkit prior to resuming sports activities after COVID-19 infection. Methods: We searched the Medline and Cochrane databases for articles on the prevalence of acute myocardial injury associated